FIELD: organic chemistry and pharmaceuticals.
SUBSTANCE: group of inventions relates to compounds useful for inhibiting general amino acid regulating kinase 2 with constant repression (GCN2). The following is disclosed: a compound of formula I or a pharmaceutically acceptable salt thereof, wherein the meaning of the radicals is as disclosed in the claims. Besides, specific compounds selected from the group, a pharmaceutical composition based on the presented compounds are disclosed, and the use of the above compounds for inhibiting GCN2 in a biological sample and for obtaining a drug is also disclosed.
EFFECT: group of inventions provides effective inhibition of GCN2.
31 cl, 19 tbl, 115 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811403C2 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
| BENZIMIDAZOLE-2-PIPERAZINE HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2649002C2 |
| NOVEL PYRROLE DERIVATIVE HAVING AS SUBSTITUTES UREIDE GROUP, AMINOCARBONYL GROUP AND BICYCLIC GROUP, OPTIONALLY SUBSTITUTED | 2009 |
|
RU2500669C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
| ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
| QUINAZOLINE DERIVATIVES | 2015 |
|
RU2704125C2 |
| CXCR7 ANTAGONISTS | 2013 |
|
RU2649004C2 |
